Shattuck Labs (STTK) · SL-846
Narrower window · A neutral label from comparing the two stated windows. It says nothing about the program’s results.
Before
Stated timing: second half of 2026
Safety and immunogenicity data are expected in the second half of 2026.
EX-99.1 · filed · SEC filing
After
Stated timing: October 17-20, 2026
Preclinical data for SL-846, including safety, pharmacokinetics, and receptor occupancy from the ongoing GLP toxicology study are expected to be presented in a poster at UEG Week, to be held October 17-20, 2026.
EX-99.1 · filed · SEC filing
Data as of . Both sentences are quoted from the SEC filings linked above and matched to them.
Source: ORION, orionbiotechai.com/changes/STTK-sl-846-2026-08-11, data as of Oct 13, 2026
https://www.orionbiotechai.com/changes/STTK-sl-846-2026-08-11
Shattuck Labs (STTK) pipeline and stated timing · Calendar · Companies A–Z